200 related articles for article (PubMed ID: 26837804)
1. Molecular Modeling of the Structural and Dynamical Changes in Calcium Channel TRPV5 Induced by the African-Specific A563T Variation.
Wang L; Holmes RP; Peng JB
Biochemistry; 2016 Mar; 55(8):1254-64. PubMed ID: 26837804
[TBL] [Abstract][Full Text] [Related]
2. Modeling the structural and dynamical changes of the epithelial calcium channel TRPV5 caused by the A563T variation based on the structure of TRPV6.
Wang L; Holmes RP; Peng JB
J Biomol Struct Dyn; 2019 Aug; 37(13):3506-3512. PubMed ID: 30175942
[TBL] [Abstract][Full Text] [Related]
3. The A563T variation of the renal epithelial calcium channel TRPV5 among African Americans enhances calcium influx.
Na T; Zhang W; Jiang Y; Liang Y; Ma HP; Warnock DG; Peng JB
Am J Physiol Renal Physiol; 2009 May; 296(5):F1042-51. PubMed ID: 19261737
[TBL] [Abstract][Full Text] [Related]
4. The L530R variation associated with recurrent kidney stones impairs the structure and function of TRPV5.
Wang L; Holmes RP; Peng JB
Biochem Biophys Res Commun; 2017 Oct; 492(3):362-367. PubMed ID: 28847730
[TBL] [Abstract][Full Text] [Related]
5. TRPV5: a Ca(2+) channel for the fine-tuning of Ca(2+) reabsorption.
Na T; Peng JB
Handb Exp Pharmacol; 2014; 222():321-57. PubMed ID: 24756712
[TBL] [Abstract][Full Text] [Related]
6. Structural basis of TRPV5 channel inhibition by econazole revealed by cryo-EM.
Hughes TET; Lodowski DT; Huynh KW; Yazici A; Del Rosario J; Kapoor A; Basak S; Samanta A; Han X; Chakrapani S; Zhou ZH; Filizola M; Rohacs T; Han S; Moiseenkova-Bell VY
Nat Struct Mol Biol; 2018 Jan; 25(1):53-60. PubMed ID: 29323279
[TBL] [Abstract][Full Text] [Related]
7. Role of the transient receptor potential vanilloid 5 (TRPV5) protein N terminus in channel activity, tetramerization, and trafficking.
de Groot T; van der Hagen EA; Verkaart S; te Boekhorst VA; Bindels RJ; Hoenderop JG
J Biol Chem; 2011 Sep; 286(37):32132-9. PubMed ID: 21795703
[TBL] [Abstract][Full Text] [Related]
8. A helix-breaking mutation in the epithelial Ca(2+) channel TRPV5 leads to reduced Ca(2+)-dependent inactivation.
Lee KP; Nair AV; Grimm C; van Zeeland F; Heller S; Bindels RJ; Hoenderop JG
Cell Calcium; 2010 Nov; 48(5):275-87. PubMed ID: 21035851
[TBL] [Abstract][Full Text] [Related]
9. The Structural Basis of Calcium-Dependent Inactivation of the Transient Receptor Potential Vanilloid 5 Channel.
Bokhovchuk FM; Bate N; Kovalevskaya NV; Goult BT; Spronk CAEM; Vuister GW
Biochemistry; 2018 May; 57(18):2623-2635. PubMed ID: 29584409
[TBL] [Abstract][Full Text] [Related]
10. Characterization of calmodulin binding domains in TRPV2 and TRPV5 C-tails.
Holakovska B; Grycova L; Bily J; Teisinger J
Amino Acids; 2011 Feb; 40(2):741-8. PubMed ID: 20686800
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms of calmodulin action on TRPV5 and modulation by parathyroid hormone.
de Groot T; Kovalevskaya NV; Verkaart S; Schilderink N; Felici M; van der Hagen EA; Bindels RJ; Vuister GW; Hoenderop JG
Mol Cell Biol; 2011 Jul; 31(14):2845-53. PubMed ID: 21576356
[TBL] [Abstract][Full Text] [Related]
12. β1-Adrenergic receptor signaling activates the epithelial calcium channel, transient receptor potential vanilloid type 5 (TRPV5), via the protein kinase A pathway.
van der Hagen EA; Tudpor K; Verkaart S; Lavrijsen M; van der Kemp A; van Zeeland F; Bindels RJ; Hoenderop JG
J Biol Chem; 2014 Jun; 289(26):18489-96. PubMed ID: 24828496
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the epithelial Ca²⁺ channel TRPV5 by reversible histidine phosphorylation mediated by NDPK-B and PHPT1.
Cai X; Srivastava S; Surindran S; Li Z; Skolnik EY
Mol Biol Cell; 2014 Apr; 25(8):1244-50. PubMed ID: 24523290
[TBL] [Abstract][Full Text] [Related]
14. TRPV5 and TRPV6 in transcellular Ca(2+) transport: regulation, gene duplication, and polymorphisms in African populations.
Peng JB
Adv Exp Med Biol; 2011; 704():239-75. PubMed ID: 21290300
[TBL] [Abstract][Full Text] [Related]
15. Functional basis for calmodulation of the TRPV5 calcium channel.
Zuidscherwoude M; van Goor MK; Roig SR; Thijssen N; van Erp M; Fransen J; van der Wijst J; Hoenderop JG
J Physiol; 2023 Feb; 601(4):859-878. PubMed ID: 36566502
[TBL] [Abstract][Full Text] [Related]
16. Tissue kallikrein stimulates Ca(2+) reabsorption via PKC-dependent plasma membrane accumulation of TRPV5.
Gkika D; Topala CN; Chang Q; Picard N; Thébault S; Houillier P; Hoenderop JG; Bindels RJ
EMBO J; 2006 Oct; 25(20):4707-16. PubMed ID: 17006539
[TBL] [Abstract][Full Text] [Related]
17. On the role of pore helix in regulation of TRPV5 by extracellular protons.
Yeh BI; Yoon J; Huang CL
J Membr Biol; 2006; 212(3):191-8. PubMed ID: 17334836
[TBL] [Abstract][Full Text] [Related]
18. Structure-based characterization of novel TRPV5 inhibitors.
Hughes TE; Del Rosario JS; Kapoor A; Yazici AT; Yudin Y; Fluck EC; Filizola M; Rohacs T; Moiseenkova-Bell VY
Elife; 2019 Oct; 8():. PubMed ID: 31647410
[TBL] [Abstract][Full Text] [Related]
19. Urinary plasmin inhibits TRPV5 in nephrotic-range proteinuria.
Tudpor K; Laínez S; Kwakernaak AJ; Kovalevskaya NV; Verkaart S; van Genesen S; van der Kemp A; Navis G; Bindels RJ; Hoenderop JG
J Am Soc Nephrol; 2012 Nov; 23(11):1824-34. PubMed ID: 23024298
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
